ClinConnect ClinConnect Logo
Search / Trial NCT07125196

Incidence of Depression and Its Complications After Surgical Site Infection - ISODEP.

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Aug 8, 2025

Trial Information

Current as of November 14, 2025

Not yet recruiting

Keywords

Surgical Site Infection Depression Malnutrition Orthopedic Surgery Mood Disorders Infection Management Prospective Study

ClinConnect Summary

This clinical trial is looking at how often depression and related problems like poor nutrition happen in people who develop infections at the site of their surgery after orthopedic operations on their limbs or spine. Surgical site infections can be serious and affect a patient’s overall well-being, so the study aims to better understand these mental health and nutrition issues to improve care and prevention for future patients.

Adults over 18 who have had surgery on their arms, legs, or spine—such as joint replacement, spinal surgery, or bone repair—and then developed an infection at the surgery site may be eligible to join. However, people with a history of depression, very low body weight, certain ongoing illnesses, or those who cannot give their consent won’t be included. Participants will be followed to see if depression or malnutrition develops after their infection, helping doctors find better ways to support patients recovering from these complications. The study is not yet recruiting but will include adults of all genders aged 65 to 74.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient \>18 years old
  • * Patient treated in infectiology for surgical site infection after orthopedic surgery of the limbs or spine:
  • Prosthetic limb surgery
  • Spinal surgery
  • Traumatology: Osteosynthesis of peripheral limbs or spine
  • Exclusion Criteria:
  • Patient under guardianship or curatorship,
  • Pregnant, breastfeeding woman
  • Person deprived of liberty by judicial or administrative decision,
  • Person undergoing psychiatric treatment under duress requiring the consent of the legal representative.
  • Person unable to express their consent,
  • Person under legal protection,
  • Patient not affiliated to a social protection scheme.
  • Patient with a history of diagnosed depression, hospitalization for depressive disorders or taking mood-regulating treatments.
  • An initial BMI of less than \< 18.5, the existence a cancerous pathology, an ongoing inflammatory disease, a pathology responsible for chronic undernutrition

About University Hospital, Bordeaux

The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.

Locations

Bordeaux, France

Patients applied

0 patients applied

Trial Officials

Benjamin BOUYER, PROF

Principal Investigator

University Hospital, Bordeaux

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported